Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.5B | 18.3B | 16.2B | 17.5B |
| Cost of revenue | 10.4B | 12.0B | 10.4B | 11.7B |
| Gross profit | 6.1B | 6.3B | 5.8B | 5.9B |
| Operating expense | ||||
| Research & development | 426M | 433M | 418M | 411M |
| Selling general and admin | 2.6B | 2.7B | 2.5B | 2.6B |
| Other operating expenses | 216M | 677M | 488M | 399M |
| Operating income | 2.8B | 2.8B | 2.7B | 2.7B |
| Non operating interest income | ||||
| Income | — | — | 154M | — |
| Expense | 64M | — | 303M | 355M |
| Other income expense | — | — | — | — |
| Pretax income | 2.7B | 2.8B | 2.5B | 2.4B |
| Tax provision | 654M | 767M | 546M | 694M |
| Net income | 2.0B | 2.1B | 2.0B | 1.7B |
| Basic EPS | 4.8 | 5.0 | 4.8 | 4.1 |
| Diluted EPS | 4.8 | 5.0 | 4.8 | 4.1 |
| Basic average shares | 413.3M | 413.3M | 413.3M | 413.3M |
| Diluted average shares | 413.3M | 413.3M | 413.3M | 413.3M |
| EBITDA | 3.3B | 3.4B | 3.4B | 3.4B |
| Net income from continuing op. | 2.8B | 2.8B | 2.7B | 2.7B |
| Minority interests | -12M | -12M | -9M | -10M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |